GlassScriptPhysician profile
Samuel Stephens Kingsley
NPI 1477851673
$6,909.76
in general payments reported to CMS, 2019-2025
17 companies · $818 in 2025
The $818 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $868 · 2021: $229 · 2022: $3,933 · 2023: $356 · 2024: $419 · 2025: $818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,593.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,500.20 | 2020-2023 | Da Vinci Surgical System |
| Kerecis Limited | $591.54 | 2019-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Medtronic, INC. | $453.50 | 2021-2025 | Sonicision, Transorb, Progrip |
| Davol INC. | $264.63 | 2022 | |
| Ethicon US, LLC | $127.26 | 2021-2025 | Echelon Flex, Stratafix |
| Medline Industries LP | $124.94 | 2019 | |
| Atricure, INC. | $124.08 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $119.04 | 2025 | |
| Hemosonics LLC | $118.07 | 2023 | Quantra Qplus System |
| Merck Sharp & Dohme LLC | $98.09 | 2020 | |
| Boston Scientific Corporation | $86.52 | 2019 | |
| W. L. Gore & Associates, INC. | $84.13 | 2025 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Janssen Pharmaceuticals, INC | $81.90 | 2022-2025 | Spravato |
| Solventum Corporation | $71.73 | 2025 | V.A.C.Instill |
| Z-Medica, LLC | $25.75 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $24.66 | 2019 | |
| Polynovo North America LLC | $13.72 | 2025 | Novosorb Btm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Kingsley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.